Altavant Sciences Is A Clinical Stage Biopharmaceutical Company Dedicated To Developing Therapies For Rare Respiratory Diseasesparticularly Pulmonary Arterial Hypertensionpahand Chronic Lung Allograft Dysfunctionclad The Company Focuses On Advancing Small Molecule And Biologic Therapies Through A Robust Clinical Pipeline And Emphasizes Translational Research To Connect Preclinical Findings With Clinical Applicationsin 2022Altavant Merged With Enzyvantenhancing Its Drug Development And Commercialization Capabilitiesthis Merger Allows For A Comprehensive Approach To Drug Developmentfrom Early Research To Market Readinessaltavant S Key Products Include Rodatristat Ethylcurrently In Phase 2B Trials For Pahand Alta 2530An Il1R1 Antagonist In Preclinical Development For Cladthe Company Also Benefits From Enzyvantae S Manufacturing Facility In North Carolinawhich Supports The Production Of Tissue Based Therapies
